Post-approval studies (Phase 4)Study completedNCT02378298What this trial is testingRituximab (RTX) Therapy in Patients With Active TAOWho this might be right forOphthalmopathy, Thyroid-Associated Göteborg University 38
Early research (Phase 1)Temporarily pausedNCT07388563What this trial is testingAzacitidine and Abatacept in Relapsed or Refractory T-Cell LymphomaWho this might be right forLymphoma, T Cell, PeripheralT-cell LymphomaAngioimmunoblastic T-cell Lymphoma+3 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00047021What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Case Comprehensive Cancer Center 3
Early research (Phase 1)Ended earlyNCT05038644What this trial is testingXmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic LeukemiaWho this might be right forAcute Myeloid LeukemiaT Cell Acute Lymphoblastic LeukemiaT Cell Lymphoblastic Lymphoma Ehab L Atallah 22
Testing effectiveness (Phase 2)Study completedNCT00636311What this trial is testingA Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's LymphomaWho this might be right forHodgkin Disease Istituto Clinico Humanitas 13
Early research (Phase 1)Ended earlyNCT03582033What this trial is testingA Safety Study of SEA-BCMA in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Seagen Inc. 83
Early research (Phase 1)Study completedNCT02519452What this trial is testingDaratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 120
Not applicableStudy completedNCT00996047What this trial is testingS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)UnknownNCT03258047What this trial is testingNovel Autologou CAR-T Therapy for Relapsed/Refractory B Cell LymphomaWho this might be right forB Cell Lymphoma First Affiliated Hospital of Zhejiang University 60
Not applicableStudy completedNCT00136838What this trial is testingEffect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2Who this might be right forTobacco Use Disorder New York State Psychiatric Institute 12
Early research (Phase 1)Study completedNCT02364492What this trial is testingA Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of RelapseWho this might be right forBreast Neoplasms Institut Pasteur 20
Testing effectiveness (Phase 2)Study completedNCT04055844What this trial is testingMulti-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDSWho this might be right forAcute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Looking for participantsNCT05745714What this trial is testingHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more Princess Maxima Center for Pediatric Oncology
Early research (Phase 1)WithdrawnNCT02640833What this trial is testingDuvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K InhibitorWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNon-Hodgkin Lymphoma AbbVie
Not applicableStudy completedNCT01436838What this trial is testingChina Betaferon Adherence, Coping and Nurse Support StudyWho this might be right forMultiple Sclerosis, Chronic Progressive Bayer 110
Not applicableStudy completedNCT00899899What this trial is testingResistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or RemissionWho this might be right forLeukemia Children's Oncology Group 135
Testing effectiveness (Phase 2)Study completedNCT06865352What this trial is testingSafety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell TransplantationWho this might be right forAcute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML) Fondazione IRCCS Policlinico San Matteo di Pavia 15
Testing effectiveness (Phase 2)Ended earlyNCT00072449What this trial is testingRituximab in Treating Patients With Refractory or Relapsed Primary CNS LymphomaWho this might be right forLymphoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Early research (Phase 1)WithdrawnNCT04279938What this trial is testingA Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCLWho this might be right forRelapsed or Refractory Diffuse Large B-cell Lymphoma Royal Marsden NHS Foundation Trust
Large-scale testing (Phase 3)Study completedNCT02574455What this trial is testingTrial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)Who this might be right forBreast Cancer Gilead Sciences 529